DaVita Inc. (DVA) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    DaVita Inc.

    NYSE: DVA · Real-Time Price · USD
    137.84
    2.28 (1.68%)
    At close: Sep 05, 2025, 3:59 PM
    137.00
    -0.61%
    Pre-market: Sep 08, 2025, 04:42 AM EDT

    DaVita Revenue Breakdown

    Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
    U S Dialysis And Related Lab Services Revenue 1.61B 5.66B 2.91B 2.84B 2.76B 2.81B 2.79B 2.73B 2.61B 2.66B 2.7B 2.66B 2.58B 2.7B 2.7B 2.68B 2.59B 2.67B 2.69B 2.67B 2.62B 2.68B 2.69B 2.64B 2.55B 2.61B 2.58B 2.63B 2.54B 2.54B 2.48B 2.43B 2.37B 2.43B 2.43B 2.37B 2.33B 2.32B 2.3B 2.25B 2.17B 2.24B 2.16B 2.11B 2.04B 2.08B 2.05B 1.99B 1.92B
    U S Dialysis And Related Lab Services Revenue Growth -71.56% +94.66% +2.29% +3.08% -1.88% +0.85% +2.00% +4.53% -1.73% -1.67% +1.50% +3.42% -4.72% +0.17% +0.81% +3.34% -3.15% -0.74% +0.72% +2.23% -2.42% -0.37% +1.86% +3.71% -2.44% +1.03% -1.83% +3.74% +0.06% +2.12% +2.22% +2.40% -2.26% -0.05% +2.61% +1.68% +0.53% +0.64% +2.21% +3.93% -3.44% +3.64% +2.80% +3.39% -1.92% +1.20% +3.18% +3.76% n/a

    Revenue by Geography

    Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
    U S Revenue 240.77M 222.72M 206.96M
    U S Revenue Growth +8.11% +7.62% n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 412.81M 374.09M 414.48M 393.53M 367.85M 362.48M 401.47M 376.88M 364.02M 331.61M 379.71M 365.45M 315.22M 294.82M 322.72M 293.1M 298.09M 281.43M 304.52M 363.28M 316.21M 263.58M 278.43M 298.74M 275.34M 250.81M 268.53M 336.3M 264.09M 266.53M 265.42M 400.02M 382.31M 391.78M 412.48M 406.89M 386.89M 386.43M 408.88M 353.49M 352.02M 341.8M
    Selling, General, and Administrative Revenue Growth +10.35% -9.75% +5.32% +6.98% +1.48% -9.71% +6.52% +3.53% +9.77% -12.67% +3.90% +15.93% +6.92% -8.65% +10.11% -1.68% +5.92% -7.58% -16.18% +14.89% +19.97% -5.33% -6.80% +8.50% +9.78% -6.60% -20.15% +27.34% -0.91% +0.42% -33.65% +4.63% -2.42% -5.02% +1.37% +5.17% +0.12% -5.49% +15.67% +0.42% +2.99% n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist